Literature DB >> 31307138

Results of staged repair of aortic disease in patients with Marfan syndrome.

Yuki Ikeno1, Koki Yokawa1, Hidekazu Nakai1, Katsuhiro Yamanaka1, Takeshi Inoue1, Hiroshi Tanaka1, Yutaka Okita2.   

Abstract

OBJECTIVE: We present our open surgical strategies for staged replacement of the thoracic and thoracoabdominal aorta in patients with Marfan syndrome.
METHODS: Between October 1999 and December 2017, 82 patients with Marfan syndrome underwent 118 aortic repairs. We divided the aorta into 4 segments for categorization: (1) the aortic root, (2) aortic arch, (3) descending thoracic, and (4) abdominal aorta. Procedures were categorized according to the types of surgery. Staged repair was defined as a subsequent operation on a different segment of the aorta after initial repair (n = 111, 94.1%), and reoperation was defined as an operation on the same segment (n = 7, 5.9%).
RESULTS: The mean age at initial operation was 41.7 ± 14.9 years. Staged repairs included aortic root replacement (n = 42, 36%), total arch replacement (n = 11, 9.3%), combined aortic root and total arch replacement (n = 13, 11%), descending aorta replacement (n = 4, 3.4%), thoracoabdominal aortic repair (n = 36, 31%), and extensive arch-descending or thoracoabdominal repair (n = 5, 4.2%). Four patients received 3 staged repairs. Operative mortality was 0.8% (1/118). Stroke occurred in 1.7% (2/118), and spinal cord injury occurred in 1.7% (2/117). Overall survival was 95.8 ± 2.4% at 10-years. Twenty-four patients underwent replacement of the whole aorta after 2.5 ± 3.8 years following initial repair.
CONCLUSIONS: Our strategies for staged replacement of the thoracic and thoracoabdominal aorta in patients with Marfan syndrome resulted in excellent early- and long-term outcomes.
Copyright © 2018 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Marfan syndrome; aortic arch replacement; aortic root replacement; aortic surgery; connective tissue disease; thoracoabdominal aortic repair

Year:  2018        PMID: 31307138     DOI: 10.1016/j.jtcvs.2018.08.109

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  6 in total

1.  Decision-making at initial surgery for type A aortic dissection in patients with Marfan syndrome: proximal or extensive repair.

Authors:  Ning Li; Yu Zhang; Yuan Gao; Yifan Bai; Zhao An; Guanxin Zhang; Qingqi Han; Fanglin Lu; BaiLing Li; Lin Han; Zhiyun Xu
Journal:  J Thorac Dis       Date:  2019-12       Impact factor: 2.895

2.  Results of open thoracoabdominal aortic replacement in patients unsuitable for or after endovascular repair with remaining disease components.

Authors:  Stoyan Kondov; Leon Frankenberger; Matthias Siepe; Cornelius Keyl; Klaus Staier; Frank Humburger; Bartosz Rylski; Maximilian Kreibich; Tim Berger; Friedhelm Beyersdorf; Martin Czerny
Journal:  Interact Cardiovasc Thorac Surg       Date:  2022-08-03

3.  Successful short interval staged surgery in synchronous type A aortic dissection and giant abdominal aortic aneurysm patient.

Authors:  Zhipeng Hu; Zhiwei Wang; Xinping Min; Bowen Li; Min Zhang; Feifeng Dai; Xin Cai
Journal:  Heliyon       Date:  2022-10-06

4.  Endovascular repair of intercostal patch aneurysms in a patient with Loyes-Dietz syndrome.

Authors:  Guilherme B Lima; Laura Ocasio; Marina Dias-Neto; Emanuel R Tenorio; Thanila A Macedo; Gustavo S Oderich
Journal:  J Vasc Surg Cases Innov Tech       Date:  2022-08-28

5.  A novel technique for the treatment of a ruptured para-anastomotic thoracic aortic aneurysm in the presence of a chronic abdominal aortic dissection.

Authors:  Hakam Sunoqrot; Daniel Silverberg; Haitam Hater; Ahmad Abu Rmeileh; Moshe Halak
Journal:  J Vasc Surg Cases Innov Tech       Date:  2021-04-20

6.  Long-term outcomes of surgical procedures for Marfan syndrome: aortic dissection versus aneurysm.

Authors:  Ning Li; Yu Zhang; Yuan Gao; Yifan Bai; Fan Qiao; Mengwei Tan; Qingqi Han; Fanglin Lu; Bailing Li; Lin Han; Guanxin Zhang; Zhiyun Xu
Journal:  J Thorac Dis       Date:  2020-03       Impact factor: 3.005

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.